Real-time enrollment status for this heart disease clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 10:10 AM UTC
| NCT Number | NCT06875973 |
| Recruiting Status | Recruiting |
| Condition | Heart Disease |
| Phase | PHASE3 |
| Target Enrollment | 599 participants |
| Active Locations | 91 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | June 11, 2026 (Jun 11, 2026) |
As of July 19, 2026: Clinical trial NCT06875973 is currently recruiting participants. This phase3 study for heart disease is actively seeking new participants at 91 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06875973 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 91 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06875973 was last updated Jun 11, 2026 (June 11, 2026). HelloStudys verifies this status automatically.